This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log in
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Oct 25;6(1):153.
doi: 10.1186/s40249-017-0367-2.

Seroprevalence of Toxoplasma gondii infection in arthritis patients in eastern China

Affiliations

Seroprevalence of Toxoplasma gondii infection in arthritis patients in eastern China

Ai-Ling Tian et al. Infect Dis Poverty. .

Abstract

Background: There is accumulating evidence for an increased susceptibility to infection in patients with arthritis. We sought to understand the epidemiology of Toxoplasma gondii infection in arthritis patients in eastern China, given the paucity of data on the magnitude of T. gondii infection in these patients.

Methods: Seroprevalence of T. gondii infection was assessed by enzyme-linked immunosorbent assay using a crude antigen of the parasite in 820 arthritic patients, and an equal number of healthy controls, from Qingdao and Weihai cities, eastern China. Sociodemographic, clinical and lifestyle information on the study participants were also obtained.

Results: The prevalence of anti-T. gondii IgG was significantly higher in arthritic patients (18.8%) compared with 12% in healthy controls (P < 0.001). Twelve patients with arthritis had anti-T. gondii IgM antibodies - comparable with 10 control patients (1.5% vs 1.2%). Demographic factors did not significantly influence these seroprevalence frequencies. The highest T. gondii infection seropositivity rate was detected in patients with rheumatoid arthritis (24.8%), followed by reactive arthritis (23.8%), osteoarthritis (19%), infectious arthritis (18.4%) and gouty arthritis (14.8%). Seroprevalence rates of rheumatoid arthritis and reactive arthritis were significantly higher when compared with controls (P < 0.001 and P = 0.002, respectively). A significant association was detected between T. gondii infection and cats being present in the home in arthritic patients (odds ratio [OR], 1.68; 95% confidence interval [CI]: 1.24 - 2.28; P = 0.001).

Conclusions: These findings are consistent with and extend previous results, providing further evidence to support a link between contact with cats and an increased risk of T. gondii infection. Our study is also the first to confirm an association between T. gondii infection and arthritis patients in China. Implications for better prevention and control of T. gondii infection in arthritis patients are discussed.

Trial registration: This is an epidemiological survey, therefore trial registration was not required.

Keywords: Arthritis; Autoimmunity; Risk factors; Seroprevalence; Toxoplasma gondii.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

The study protocol was reviewed and approved by the Ethics Committee of the Medical College of Qingdao University and Wenhaiwei People’s Hospital. Patients were made aware of the aim of the study. Each individual provided written consent for their participation in the study. Informed consent was obtained from parents or guardians of children before enrolment in the study. Control sera were collected from volunteers.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Maps of the study sites showing the location of Qingdao and Weihai cities in Shandong province, eastern China

References

    1. Dubey JP. Toxoplasmosis of animals and humans. 2. Florida: CRC Press; 2010. p. 313.
    1. McLeod R, Kieffer F, Sautter M, Hosten T, Pelloux H. Why prevent, diagnose and treat congenital toxoplasmosis? Mem Inst Oswaldo Cruz. 2009;104:320–344. doi: 10.1590/S0074-02762009000200029. - DOI - PMC - PubMed
    1. Choi WY, Nam HW, Kwak NH, Huh W, Kim YR, Kang MW, et al. Foodborne outbreaks of human toxoplasmosis. J Infect Dis. 1997;175:1280–1282. doi: 10.1086/593702. - DOI - PubMed
    1. Phan L, Kaszab K, Jalbrzikowski J, Noblea AG, Latkany P, Kuo A, et al. Longitudinal study of new eye lesions in children with toxoplasmosis who were not treated during the first year of life. Am J Ophthalmol. 2008;146:375–384. doi: 10.1016/j.ajo.2008年04月03日3. - DOI - PMC - PubMed
    1. Elsheikha HM. Congenital toxoplasmosis: priorities for further health promotion action. Public Health. 2008;122:335–353. doi: 10.1016/j.puhe.200708009. - DOI - PubMed

MeSH terms

Cite

AltStyle によって変換されたページ (->オリジナル) /